Y. Murata et al. / Tetrahedron Letters 43 (2002) 8121–8123
8123
References
1. Recent Progress in the Chemical Synthesis of Antibiotics;
Lukacs, G.; Ohno, M., Eds.; Springer: Berlin, 1990.
2. Crispino, G. A.; Jeong, K.-S.; Kolb, H. C.; Wang, Z.-M.;
Xu, D.; Sharpless, K. B. J. Org. Chem. 1993, 58, 3785–
3786.
3. Corey, E. J.; Jardine, P. D.; Virgil, S.; Yuen, P.-W.;
Connell, R. D. J. Am. Chem. Soc. 1989, 111, 9243–9244.
4. Kamino, T.; Murata, Y.; Kawai, N.; Hosokawa, S.;
Kobayashi, S. Tetrahedron Lett. 2001, 42, 5249–5252.
5. Mukaiyama et al. also reported a similar stereocontrolled
preparation of syn- and anti-1,2-diol by choice of the
protecting group of the E-O-enolate derived from glycolic
acid. Benzyloxy derivative afforded an anti isomer through
the coordination of the benzyloxy group to a Lewis acid,
whereas the t-butyldimethylsiloxy derivative gave a syn
isomer through an extended transition state. Therefore, the
aldol reaction proceeds in a stereoselective manner regard-
less the stereochemistry of an enolate; Mukaiyama, T.;
Shiina, I.; Uchiro, H.; Kobayashi, S. Bull. Chem. Soc. Jpn.
1994, 67, 1708–1716.
Scheme 4. Trapping of enolate by silylation or alkylation.
6. Davies, S. G.; Sangnee, H. J.; Szolcsanyi, P. Tetrahedron
1999, 55, 3337–3354.
Figure 1.
7. General procedure: To a solution of LDA (prepared from
DIPA (46.7 ml, 356 mmol), and BuLi (2.6 M in hexane, 129
ml, 335 mmol) at −78°C for 15 min) was added a solution
of 5 (71.1 mg, 223 mmol) at −78°C. After stirring for 30
min at −78°C, Ti(O-i-Pr)3Cl (1.0 M in hexane, 0.89 ml,
892 mmol) was added and the resulting mixture was stirred
for 1 h at −40°C. After cooling to −78°C, crotonaldehyde
(21.6 ml, 268 mmol) was added to the mixture which was
additionally stirred at −40°C for 2 h. The reaction mixture
was quenched with satd NH4Cl and stirred with Celite for
1 h at rt. Filtration and evaporation gave a crude oil,
which was purified by column chromatography (hex-
ane:AcOEt=10:1) to yield 6 (71.1 mg, 88%) and 7 (6.4 mg,
8%). 6: Rf=0.43 (hexane:AcOEt=2:1); [h]2D3 +33.7 (c 2.11
was confirmed by NMR study of isolated 17. Thus,
NOE was observed between OMe and t-BuMe2Si.
NOE between olefinic Me and Ph was also observed
(Scheme 4).8 Although the precise mechanism is not
clear, we assume that the E-O-enolate is thermodynam-
ically favored considering an electronic repulsion
between the a-alkoxyl group and the enolate anion,
thus affording E-O-enolate 16 in the case of benzyloxy
derivative 12. On the other hand, the selective forma-
tion of Z-O-enolate 17 might be due to the serious
steric repulsion between the TBS group and the oxazo-
lidine moiety in the E-O-enolate.
1
CHCl3); H NMR (500 MHz, CDCl3): l (ppm) 0.98 (3H,
Based on these results, plausible transition states of the
present titanium-mediated aldol reaction are shown in
Fig. 1. Thus, carbonyl oxygen of the oxazolidine-2-one
coordinates to titanium, and an aldehyde approaches
from the less hindered side (opposite to the phenyl
group in 18 and 19). Both relative and stereochemical
course of the present aldol reaction could be rationally
explained by transition states 18 and 19.
d, J=7.0 Hz), 1.02 (3H, d, J=6.7 Hz), 1.32 (3H, s), 1.48
(3H, s), 1.67 (3H, dd, J=1.2, 6.4 Hz), 1.79 (3H, s),
2.12–2.16 (1H, m), 3.67 (bs, 1H), 4.26 (1H, d, J=3.7 Hz),
4.58 (1H, d, J=10.4 Hz), 4.63 (1H, d, J=10.7 Hz), 4.89
(1H, t, J=7.3 Hz), 5.62 (1H, ddd, J=1.53, 8.2, 15.4 Hz),
5.77 (1H, dq, J=6.4, 15.6 Hz), 7.26–7.41 (5H, m); 13C
NMR (100 MHz, CDCl3): l (ppm) 17.0, 17.6, 17.7, 21.2,
21.5, 28.3, 30.0, 66.3, 68.2, 74.4, 82.6, 86.6, 127.4, 127.5,
128.2, 129.5, 129.6, 138.1, 152.5, 173.0; IR (neat) 3518,
2976, 1778, 1695, 1497, 1359, 1125, 971, 735, 698; HR-
FABMS: calcd for C22H32O5N ([M−H]+) 389.2281, found
389.2286.
In conclusion, we were able to develop a general and
stereoselective route to 1,2-diols including a quaternary
chiral center. Particularly noteworthy is that all the
chiral center could be controlled by the proper choice
of a protecting group and an oxazolidin-2-one. The
present methodology could be applicable to the synthe-
sis of various biologically interesting compounds, and
further studies along this line are now in progress.
8. 16: 1H NMR (400 MHz, CDCl3) l (ppm) 0.76 (6H, q,
J=1.95 Hz), 0.88 (3H, s), 1.00 (9H, t, J=1.94 Hz), 1.48
(3H, s), 4.76 (1H, d, J=11.0 Hz), 4.81 (1H, s), 4.89 (1H, d,
J=11.0) 7.25–7.45 (10H, m); 13C NMR (100 MHz,
CDCl3) l (ppm) 4.86, 6.72, 13.15, 23.80, 27.49, 69.68,
71.02, 81.71, 127.54, 127.63, 127.75, 128.16, 128.24, 128.24,
1
128.26, 134.79, 136.46, 137.96, 155.49. 17: H NMR (400
Acknowledgements
MHz, CDCl3) l (ppm) 0.00 (3H, s), 0.12 (3H, s), 0.98 (9H,
s), 1.15 (3H, s), 1.97 (3H, s), 3.52 (3H, s), 4.85 (1H, s),
7.31–7.50 (5H, m); 13C NMR (100 MHz, CDCl3) l (ppm)
−5.21, −4.76, 17.98, 18.34, 23.69, 25.53, 27.97, 58.06,
69.00, 81.74, 127.71, 128.39, 128.58, 131.68, 134.67, 136.65,
155.88.
This work was financially supported in part by Grant-
in-Aid for Scientific Research from the Ministry of
Education, Culture, Sports, Science and Technology.